Understanding these mechanisms not only sheds light on bacterial pathogenesis but also identifies PapB and its homologs as potential targets for inhibiting some types of fimbriae as a targeted strategy to prevent bacterial infections dependent on Pap B-family regulators. This evidence concerns the gene GLI3 and bacterial infectious disease.